Physician profile
William Sorrells
NPI 1962856849
$18,493.58
in general payments reported to CMS, 2019-2025
24 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2021: $1,263 · 2022: $8,353 · 2023: $2,351 · 2024: $2,011 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,374 · Food and Beverage: $4,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,373.53 |
| Food and Beverage | $4,327.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,217.56 | 2021-2025 | Turbohawk, Hawkone, Endurant Iis |
| W. L. Gore & Associates, INC. | $2,949.43 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $1,167.13 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $888.95 | 2025 | Indigo System, Ruby Coil, Penumbra System |
| Shockwave Medical, INC | $531.34 | 2025 | |
| Bolton Medical INC | $331.16 | 2021-2025 | Treo Abdominal Stent-Graft System |
| Abbott Laboratories | $257.83 | 2021-2022 | |
| Endologix LLC | $189.61 | 2019-2024 | Endocross Device, Torus Stent Graft System |
| Boston Scientific Corporation | $185.41 | 2023-2025 | General - Vascular Intervention, General - Atherectomy, Enroute Transcarotid Neuroprotection System |
| Janssen Scientific Affairs, LLC | $125.00 | 2021 | |
| Cvrx, INC. | $122.67 | 2023 | Barostim Neo System |
| Cook Medical LLC | $108.61 | 2021 | |
| Edwards Lifesciences Corporation | $95.53 | 2023-2025 | Konect Resilia, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Inspiremd LTD | $76.09 | 2025 | Cguard Prime Carotid Stent System |
| Ethicon US, LLC | $52.50 | 2025 | Vistaseal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $40.83 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $35.19 | 2025 | Matrixrib |
| Team 1, LLC | $20.52 | 2025 | |
| Solventum Corporation | $19.11 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Centerline Biomedical INC. | $18.43 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.86 | 2023 | Xarelto |
| Baxter Healthcare | $15.28 | 2025 | Perclot |
| Mimedx Group, INC. | $14.50 | 2025 | |
| Lemaitre Vascular, INC. | $14.04 | 2023 | Hydro Lemaitre Valvulotome |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sorrells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.